×
About 1,481 results

ALLMedicine™ Prolactinoma Center

Research & Reviews  729 results

COVID-19-induced anosmia associated with olfactory bulb atrophy.
https://doi.org/10.1007/s00234-020-02554-1
Neuroradiology Chiu A, Fischbein N et. al.

Sep 15th, 2020 - As the global COVID-19 pandemic evolves, our knowledge of the respiratory and non-respiratory symptoms continues to grow. One such symptom, anosmia, may be a neurologic marker of coronavirus infection and the initial presentation of infected patie...

Predictors of the Response to Dopaminergic Therapy in Patients with Prolactinoma.
https://doi.org/10.1210/clinem/dgaa652
The Journal of Clinical Endocrinology and Metabolism; Hage C, Salvatori R

Sep 15th, 2020 - Withdrawal of dopamine agonist (DA) therapy in patients with prolactinoma who are controlled by a small dose of medication is recommended by several guidelines. So far, the likelihood of reaching withdrawal conditions based on baseline characteris...

Inhibiting MAPK14 showed anti-prolactinoma effect.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487756
BMC Endocrine Disorders; Ding QY, Zhang Y et. al.

Sep 7th, 2020 - The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38α MAPK (MAPK14), p38β (MAPK11), p38γ (MAPK12) and p38δ (MAPK13) is as...

Treatment Strategy for Giant Invasive Macroprolactinoma with Spontaneous Cerebrospinal ...
https://doi.org/10.1016/j.wneu.2020.08.129
World Neurosurgery; Abe D, Ogiwara T et. al.

Aug 27th, 2020 - Spontaneous cerebrospinal fluid (CSF) rhinorrhea associated with untreated prolactinomas is rare, which is in contrast to medical treatment-induced CSF rhinorrhea. Previous studies suggested that cessation of drug administration should be the firs...

Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controll...
https://doi.org/10.1111/jdi.13369
Journal of Diabetes Investigation References; Igata M, Yagi Y et. al.

Jul 24th, 2020 - Dopamine receptor agonists are typically used to treat Parkinson's disease and certain pituitary tumors, such as prolactinoma or a growth hormone-producing tumor. A 53-year-old woman with a history of prolactinoma was referred to Kumamoto Universi...

see more →

Clinicaltrials.gov  741 results

COVID-19-induced anosmia associated with olfactory bulb atrophy.
https://doi.org/10.1007/s00234-020-02554-1
Neuroradiology Chiu A, Fischbein N et. al.

Sep 15th, 2020 - As the global COVID-19 pandemic evolves, our knowledge of the respiratory and non-respiratory symptoms continues to grow. One such symptom, anosmia, may be a neurologic marker of coronavirus infection and the initial presentation of infected patie...

Predictors of the Response to Dopaminergic Therapy in Patients with Prolactinoma.
https://doi.org/10.1210/clinem/dgaa652
The Journal of Clinical Endocrinology and Metabolism; Hage C, Salvatori R

Sep 15th, 2020 - Withdrawal of dopamine agonist (DA) therapy in patients with prolactinoma who are controlled by a small dose of medication is recommended by several guidelines. So far, the likelihood of reaching withdrawal conditions based on baseline characteris...

Inhibiting MAPK14 showed anti-prolactinoma effect.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487756
BMC Endocrine Disorders; Ding QY, Zhang Y et. al.

Sep 7th, 2020 - The specific underlying pathogenesis of prolactinoma has not been clarified yet, to the best of our knowledge. p38 mitogen-activated protein kinase (MAPK) signaling including p38α MAPK (MAPK14), p38β (MAPK11), p38γ (MAPK12) and p38δ (MAPK13) is as...

Treatment Strategy for Giant Invasive Macroprolactinoma with Spontaneous Cerebrospinal ...
https://doi.org/10.1016/j.wneu.2020.08.129
World Neurosurgery; Abe D, Ogiwara T et. al.

Aug 27th, 2020 - Spontaneous cerebrospinal fluid (CSF) rhinorrhea associated with untreated prolactinomas is rare, which is in contrast to medical treatment-induced CSF rhinorrhea. Previous studies suggested that cessation of drug administration should be the firs...

Rapid and dramatic glucose-lowering effect of bromocriptine in an inadequately controll...
https://doi.org/10.1111/jdi.13369
Journal of Diabetes Investigation References; Igata M, Yagi Y et. al.

Jul 24th, 2020 - Dopamine receptor agonists are typically used to treat Parkinson's disease and certain pituitary tumors, such as prolactinoma or a growth hormone-producing tumor. A 53-year-old woman with a history of prolactinoma was referred to Kumamoto Universi...

see more →

News  4 results

Prolactin, the pituitary, and pregnancy: Where’s the balance?
https://www.mdedge.com/familymedicine/article/164370/pituitary-thyroid-adrenal-disorders/prolactin-pituitary-and-pregnancy/page/0/3
Clinical Endocrinology News;

Apr 26th, 2018 - What if the tumor grows in pregnancy? During pregnancy, high estrogen levels from the placenta can stimulate prolactinoma growth, and the dopamine agonist’s inhibitory effect is gone once that medication’s been stopped. This means that “We have bo.

Pituitary Incidentaloma
https://www.mdedge.com/clinicianreviews/article/96669/endocrinology/pituitary-incidentaloma/page/0/1

Jan 26th, 2015 - SHOULD AN ASYMPTOMATIC PATIENT BE EVALUATED FURTHER? Endocrine Society guidelines2 recommend that all patients with pituitary incidentaloma, with or without symptoms, should undergo a complete history and physical examination and laboratory evalua.

Prolactinoma: A Case Study
https://www.mdedge.com/clinicianreviews/article/72153/endocrinology/prolactinoma-case-study/page/0/1

Nov 1st, 2011 - Dopamine agonists are approximately 80% to 90% effective in decreasing prolactin levels and reducing tumor size in microadenomas and 60% to 70% in macroadenomas. The major drawback of using medication is that it does not always provide permanent r.

Endocrine Society Releases Guidelines on Pituitary Incidentalomas
https://www.mdedge.com/internalmedicine/article/34059/endocrinology/endocrine-society-releases-guidelines-pituitary
Elizabeth Mechcatie

Apr 20th, 2011 - Surgical treatment of a pituitary incidentaloma is recommended when the lesion is causing a visual field deficit or other visual abnormalities, such as ophthalmoplegia "or neurological compromise," according to evidence-based clinical practice gui.

see more →

Patient Education  7 results see all →